We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
4d Pharma Plc | LSE:DDDD | London | Ordinary Share | GB00BJL5BR07 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 16.36 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
05/10/2022 15:38 | It clearly says who is doing the presentations. | the donald | |
05/10/2022 15:37 | Why RNS about 2 presentations next month. If not relisting as a PLC, they would not need to put this information out. | the donald | |
05/10/2022 14:44 | Whose going to present the posters? | blueblood | |
05/10/2022 14:37 | What makes you say that? | blueblood | |
05/10/2022 13:40 | Looking good for a relist soon. | the donald | |
05/10/2022 13:22 | Seres pharmaceutical valued at 700 million ....Nearest rival in this space | amaretto1 | |
30/9/2022 09:25 | If, like MILLSTONE INVESTOR, you lost ALL YOUR MONEY on 4d Pharma, this is for you | buy2sell1 | |
29/9/2022 13:26 | Promising I guess Anything better than zero | thiopia | |
29/9/2022 12:39 | Admins racking up a huge bill... | millennialinvestor | |
29/9/2022 10:59 | Further to the publication of the Joint Administrators' Proposals on August 4 2022, the Joint Administrators continue to evaluate potential avenues to return the Company from administration and this process is ongoing. Further announcements will be made in due course. | neilyb675 | |
29/9/2022 10:35 | It does but imo any sort of sale (whole or part) would have been done by now. | the donald | |
29/9/2022 10:33 | Donny - a part sale (of an asset eg Blautix) also fits that statement. That In itself it could provide refinancing/part refinancing Cautiously optimistic. | backbone and clingfilm | |
29/9/2022 10:19 | 'Further to the publication of the Joint Administrators' Proposals on August 4 2022, the Joint Administrators continue to evaluate potential avenues to return the Company from administration and this process is ongoing. Further announcements will be made in due course.' If this was being wrapped up for a sale, surely that would be an option in this statement. Returning company from admin is a refinance rather than a sale. Looking encouraging | the donald | |
29/9/2022 10:07 | RNS .... Mmmmm Still talking .. | amaretto1 | |
26/9/2022 10:39 | Look at the dollar exchange rate ...Absolute no brainer !!! But ... | amaretto1 | |
26/9/2022 09:48 | Merck can probably pick this up for less than the milestone payments on the vaccine work. They have the ongoing costs of running 4D though. | 1airbag | |
25/9/2022 21:54 | That's exactly what it is Colin and Big Pharma are not in business for solving the worlds health needs but how they can fully capitalise upon them in the longer-term...And this certainly isn't a moral crusade for them! | one_frankel | |
20/9/2022 10:25 | 𝐅𝐨 𝐈 𝐤𝐧 𝐓𝐡 𝐀 𝐥𝐨 𝐛𝐮 𝐓𝐡 𝐓𝐡 𝐓𝐡 |